Switzerland· 68290001

Akynzeo IV

A palonosetron, kombinationen product containing fosnetupitantum, palonosetronum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC A04AA55

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAkynzeo IVATCA04AA55REGISTER NO.68290001PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Palonosetron, kombinationen is registered in 11 of 19 countries.

Countries holding a registration under ATC A04AA55 (palonosetron, kombinationen), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 7 of them publish a price we can compare per daily dose

Palonosetron, kombinationen · ATC A04AA55

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of palonosetron, kombinationen costs, country by country.

Normalised to the WHO defined daily dose (0.5 mg), so markets compare like for like.

  • Switzerland: $0.20 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown

Palonosetron, kombinationen · price per daily dose (0.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.20
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
fosnetupitantum, palonosetronum
Manufacturer
—
Country
Switzerland (CH)
ATC code
A04AA55
ATC class
Palonosetron, Kombinationen
Defined daily dose
0.5 mg, O
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680682900015
    Durchstf 20 ml
    CHF 100.95

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Palonosetron, kombinationen in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All palonosetron, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Akynzeo
  • Liechtenstein · Akynzeo
  • Norway · Akynzeo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/45193b90-2182-410a-9f79-54438cfccab3
GET /v1/drugs/45193b90-2182-410a-9f79-54438cfccab3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "fosnetupitantum 235 mg + palonosetronum 0.25 mg",
  "valid_from": "2024-06-01",
  "limitations": "[{\"description\":\"In Kombination mit Dexamethason für Erwachsene:<br>\\n- zur Prävention von akuter und verzögerter Übelkeit und Erbrechen bei stark emetogener zytostatischer Chemotherapie;<br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2024-06-01\",\"validTo\":null}]",
  "galenic_form": "Inf Konz 235mg/0.25mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2024-06-01",
  "self_retention_pct": 10
}

See everything about palonosetron, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.